Does MARSTACIMAB-HNCQ Cause Haemarthrosis? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Haemarthrosis have been filed in association with MARSTACIMAB-HNCQ. This represents 38.5% of all adverse event reports for MARSTACIMAB-HNCQ.
5
Reports of Haemarthrosis with MARSTACIMAB-HNCQ
38.5%
of all MARSTACIMAB-HNCQ reports
0
Deaths
0
Hospitalizations
How Dangerous Is Haemarthrosis From MARSTACIMAB-HNCQ?
Of the 5 reports.
Is Haemarthrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MARSTACIMAB-HNCQ. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does MARSTACIMAB-HNCQ Cause?
What Other Drugs Cause Haemarthrosis?
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (3,360)
EMICIZUMAB-KXWH (487)
RIVAROXABAN (429)
COAGULATION FACTOR IX RECOMBINANT HUMAN (318)
DAMOCTOCOG ALFA PEGOL (299)
--BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 (220)
ASPIRIN (208)
EFTRENONACOG ALFA (196)
COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL (190)
APIXABAN (169)